DaVita HealthCare Partners Inc (DVA)
$207.91
$-2.67
(-1.27%)
As on 18-Jun-2026 19:00EDT
Market cap
$13,345 Mln
Revenue (TTM)
$13,835 Mln
P/E Ratio
20
P/B Ratio
21.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$584 Mln
-
ROE
0.8 %
-
ROCE
5.3 %
-
Industry P/E
39.49
-
EV/EBITDA
9.6
-
Debt to Equity
-13.9
-
Book Value
$--
-
EPS
$10.1
-
Face value
--
-
Shares outstanding
64,185,000
10 Years Aggregate
CFO
$18,269.91 Mln
EBITDA
$22,956.97 Mln
Net Profit
$7,349.22 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| 83.0 | 4.1 | 38.6 | 52.3 | 28.7 | 11.0 | 10.7 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| -24.0 | 42.3 | 40.3 | -34.4 | -3.1 | 56.5 | 45.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
|
207.9 | 13,344.7 | 13,835.1 | 781.4 | 14.3 | -- | 20 | 21.6 |
| 98.3 | 125,449.2 | 407,905.0 | 2,932.0 | 1.6 | 3.9 | 43.1 | 1.6 | |
| 98.0 | 9,724.5 | 6,066.4 | 609.2 | 18.6 | 16.7 | 16.8 | 3.9 | |
| 375.2 | 83,227.6 | 76,388.0 | 6,794.0 | 15.8 | -- | 12.9 | 291.3 | |
| 35.5 | 8,209.8 | 2,369.7 | -13.2 | -1.6 | -2.6 | -- | 18.4 | |
| 255.8 | 20,977.2 | 14,144.2 | 941.5 | 9.7 | 10.8 | 22.7 | 2.4 | |
| 195.0 | 21,585.8 | 11,278.0 | 1,024.0 | 14.7 | 13.3 | 21.5 | 2.9 | |
| 172.6 | 14,864.7 | 21,455.0 | 1,703.0 | 18.6 | 17.1 | 9 | 3.1 | |
| 153.7 | 8,730.0 | 5,274.0 | 363.4 | 9.2 | 16.2 | 24.3 | 3.7 | |
| 141.2 | 8,545.9 | 17,760.3 | 1,520.8 | 12.2 | 20.2 | 5.9 | 1.1 |
Shareholding Pattern
View DetailsAbout DaVita HealthCare Partners Inc (DVA)
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers... outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Read more
-
CEO & Executive Director
Mr. Javier J. Rodriguez
-
CEO & Executive Director
Mr. Javier J. Rodriguez
-
Headquarters
Denver, CO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for DaVita HealthCare Partners Inc (DVA)
What is the current share price of DaVita HealthCare Partners Inc (DVA) Today?
The share price of DaVita HealthCare Partners Inc (DVA) is $207.91 (NYSE) as of 18-Jun-2026 19:00 EDT. DaVita HealthCare Partners Inc (DVA) has given a return of 28.66% in the last 3 years.
What is the current PB & PE ratio of DaVita HealthCare Partners Inc (DVA)?
The P/E ratio of DaVita HealthCare Partners Inc (DVA) is 20.01 times as on 18-Jun-2026, a 49 discount to its peers’ median range of 39.49 times.
The P/B ratio of DaVita HealthCare Partners Inc (DVA) is 21.63 times as on 18-Jun-2026, a 602 premium to its peers’ median range of 3.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.40
|
8.64
|
|
2024
|
13.70
|
6.14
|
|
2023
|
14.06
|
3.54
|
|
2022
|
12.25
|
3.08
|
|
2021
|
12.19
|
5.03
|
What is the 52 Week High and Low of DaVita HealthCare Partners Inc (DVA)?
The 52-week high and low of DaVita HealthCare Partners Inc (DVA) are Rs 213.32 and Rs 102.26 as of 20-Jun-2026.
What is the market cap of DaVita HealthCare Partners Inc (DVA)?
DaVita HealthCare Partners Inc (DVA) has a market capitalisation of $ 13,345 Mln as on 18-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in DaVita HealthCare Partners Inc (DVA)?
Before investing in DaVita HealthCare Partners Inc (DVA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.